Cargando…
Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapies
In recent years, recurrent somatic mutations in epigenetic regulators have been identified in patients with hematological malignancies. Furthermore, chromosomal translocations in which the fusion protein partners are themselves epigenetic regulators or where epigenetic regulators are recruited/targe...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302993/ https://www.ncbi.nlm.nih.gov/pubmed/27329599 http://dx.doi.org/10.18632/oncotarget.10033 |